ERBB2 and breast carcinoma: To assess whether GECKO could identify k-mers that classify breast cancer subtypes, we used a dataset of 1087 mRNA-Seq breast cancer samples from the Cancer Genome Atlas Pan-Gyn cohort13 (patients per class: Basal 175, Her2 73, LumA 513, LumB 185).